LZ Lifescience unveils 'disruptive' launch
By replacing traditional paper-based systems with MES, companies are able to deal with exceptions in real-time so that batch records and device history records can be reviewed in parallel with manufacturing rather than post production.
Manufacturing software specialist LZ Lifescience is set to launch its latest product to the global pharmaceutical industry in a bid to shake up the marketplace by offering manufacturers ‘affordable access’ to a Manufacturing Execution System (MES).
Shopfloor-Online is a well-established, web-based product that has already been installed with hundreds of customers in different sectors across the world and the creation of the Lifescience edition has extended its functionality to meet the demanding MES requirements of the life science sector.
Driven by market demand, its launch comes at a time when there is increased pressure on IT and infrastructure spend across the pharmaceutical and outsourcing industry, which has become a reported industry-issue over the last few years.
Designed specifically for pharmaceutical companies, the online production management system focuses on plant operations so materials flow smoothly to help companies achieve ‘Right First Time’ manufacturing and faster product release.
To bolster its global launch initiative, LZ Lifescience has secured the services of high-profile MES executive Christian Fortunel to run its operations in the US as vice president and increase the software’s global reach.
Tim Barber, chairman and board director at LZ Lifescience, said: “We are delighted to have Christian on board and his appointment comes at a very exciting time as we launch our new MES product to the world.
“We firmly believe current MES options on the market are price prohibitive for most tier-2 pharmaceutical, medical device, biotechnology and contract manufacturing organisations. Our aim with Shopfloor-Online is to therefore disrupt the sector by providing manufacturers of all sizes a genuinely affordable option to automate production management systems.
“Our software allows organisations to simultaneously manage scheduling, production execution, workflow, quality and inventory all in place to increase plant production efficiency, reduce the risk and meet current regulations.
“It significantly reduces the pricing barriers and complex nature of the traditional MES, without sacrificing functionality. By reducing errors, costs and waste, Shopfloor-Online will boost productivity by 25%. With this in mind, we are confident most clients will realise a return on investment in just a year,” added Tim.
With over 15 years’ experience in providing production management solutions to the life science industry, Christian has worked in the software sector in numerous executive positions.
New appointment Christian said: “I am very excited to join LZ Lifescience. With its Shopfloor-Online software product, I believe it offers, by far, the best value to the life science industry to establish electronic records that meet all regulatory requirements.
“There is a mindset change underway across the industry with regards to firms being open about adopting and deploying web-based solutions and online tools so the timing of our launch could not be better.
“By offering companies a modular approach to pick, choose and build functionality based on their process and facility requirements, we are providing clients a level of flexibility that is not currently available on the market.”
Supported by a strong engineering division, the well-established Shopfloor-Online is already used by hundreds of clients worldwide. This new version will assist life science companies with improved regulatory compliance, lower production costs, a centralised point of information, increased equipment efficiency and reduced waste and inventory.
By replacing traditional paper-based systems with MES, companies are able to deal with exceptions in real-time so that batch records and device history records can be reviewed in parallel with manufacturing rather than post production.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance